Propeller Health

Why Propeller Health?

Propeller Health is the leading digital platform for respiratory health management.

Through sensors, mobile apps and services, Propeller Health is closing the gap between what can be accomplished in asthma, chronic obstructive pulmonary disease (“COPD”) and chronic respiratory disease and what little has so far been achieved. This means significantly improving the quality of care, reducing unnecessary morbidity and utilization, and enabling a modern, cost-effective, data-driven approach to management.

Using small sensors to record when and where people use inhaled medications, Propeller Health provides patients with a continuous, objective assessment of their disease, together with personalized guidance and targeted education, drawn from the national guidelines, to help them improve.

Interfaces powered by advanced analytics, allow physicians and healthcare providers to remotely monitor patients and identify those who need more help. The sensors also provide public health agencies with the first real-time geospatial view of disease burden in the community allowing them to focus their efforts on prevention and target their resources as never before.

Propeller Health is working with organizations like Dignity Health, Wyckoff Heights Medical Center, Amerigroup Florida and the City of Louisville.

Market Opportunity

Asthma and COPD currently cost payers and patients in the U.S. more than $100 billion annually. By 2020, the CDC estimates that the cost of medical care for adults in the U.S. with COPD alone will increase 53% to more than $90 billion.

(Visited 733 times, 1 visits today)

Company Milestones

  • Founded as Asthmapolis
  • Asthmapolis introduces new inhaler sensor that integrates with mobile phones
  • Asthmapolis receives FDA clearance for asthma inhaler sensor technology and accompanying software system
  • Asthmapolis partners with Amerigroup to enhance asthma management efforts
  • Asthmapolis relaunches as Propeller Health Health
  • Propeller Health receives FDA clearance for its next-generation Propeller Health platform and sensor
  • Propeller Health receives FDA clearance for the Propeller Health Platform in association with Boehringer Ingelheim’s Respimat® Inhaler and GSK’s Diskus® Inhaler
  • Propeller Health announces R&D collaboration with GSK to develop a digital sensor for the Ellipta® inhaler
  • Propeller Health partners with Aptar Pharma to develop the world's first integrated, connected meter dose inhaler
  • Propeller Health partners with Boehringer Ingelheim to improve adherence and care management for COPD and asthma patients
  • Propeller Health partners with AMC Health to improve care manaegement for COPD and asthma patients
  • Propeller Health partners with Vectura to develop digitally-connected inhalers to address chronic respiratory diseases
  • Propeller Health partners with Molina Healthcare to improve outcomes and quality of care for patients with asthma